Walgreens Boots Alliance, Inc. WBA
We take great care to ensure that the data presented and summarized in this overview for Walgreens Boots Alliance, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding WBA
View all-
Vanguard Group Inc Valley Forge, PA82.3MShares$972 Million0.04% of portfolio
-
Black Rock Inc. New York, NY68.1MShares$805 Million0.03% of portfolio
-
State Street Corp Boston, MA36.2MShares$428 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA29.1MShares$344 Million0.11% of portfolio
-
Geode Capital Management, LLC Boston, MA18.9MShares$223 Million0.04% of portfolio
-
Invesco Ltd. Atlanta, GA17.3MShares$205 Million0.08% of portfolio
-
Morgan Stanley New York, NY12.6MShares$149 Million0.02% of portfolio
-
Camber Capital Management LP Boston, MA7.8MShares$92.2 Million4.15% of portfolio
-
Northern Trust Corp Chicago, IL7.34MShares$86.7 Million0.03% of portfolio
-
Legal & General Group PLC London, X07.24MShares$85.6 Million0.04% of portfolio
Latest Institutional Activity in WBA
Top Purchases
Top Sells
About WBA
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Insider Transactions at WBA
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2024
|
Mary Langowksi EVP, President U.S. Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
256,739
+50.0%
|
-
|
|
Jun 01
2024
|
Lanesha Minnix EVP and Global CLO |
BUY
Grant, award, or other acquisition
|
Direct |
186,136
+50.0%
|
-
|
|
Jun 01
2024
|
Elizabeth Burger EVP, Global Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
160,462
+50.0%
|
-
|
|
Apr 23
2024
|
Tracey D Brown EVP, Pres., Walgreens Retail |
SELL
Payment of exercise price or tax liability
|
Direct |
3,489
-1.94%
|
$62,802
$18.22 P/Share
|
|
Apr 23
2024
|
Tracey D Brown EVP, Pres., Walgreens Retail |
BUY
Grant, award, or other acquisition
|
Direct |
11,594
+6.06%
|
-
|
|
Apr 11
2024
|
Inderpal S Bhandari Director |
BUY
Open market or private purchase
|
Direct |
3,000
+50.0%
|
$54,000
$18.05 P/Share
|
|
Apr 02
2024
|
Manmohan Mahajan EVP and Global CFO |
BUY
Open market or private purchase
|
Direct |
6,000
+3.47%
|
$114,000
$19.38 P/Share
|
|
Mar 01
2024
|
Beth Amber L. Fabbri Chief Corp. Affairs Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,052
+21.01%
|
-
|
|
Mar 01
2024
|
Todd Heckman SVP, Global Controller and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
12,541
+23.35%
|
-
|
|
Mar 01
2024
|
Tracey D Brown EVP, Pres., Walgreens Retail |
BUY
Grant, award, or other acquisition
|
Direct |
11,219
+6.25%
|
-
|
|
Mar 01
2024
|
Manmohan Mahajan EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
101,874
+38.76%
|
-
|
|
Jan 29
2024
|
Valerie B Jarrett Director |
BUY
Open market or private purchase
|
Direct |
4,456
+50.0%
|
$98,032
$22.44 P/Share
|
|
Jan 16
2024
|
Nancy M Schlichting Director |
SELL
Open market or private sale
|
Direct |
15,209
-100.0%
|
$349,807
$23.05 P/Share
|
|
Jan 05
2024
|
Timothy C Wentworth Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+1.68%
|
$240,000
$24.22 P/Share
|
|
Nov 10
2023
|
Richard P. Gates SVP, Chief Pharmacy Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.33%
|
$20,000
$20.45 P/Share
|
|
Nov 01
2023
|
Timothy C Wentworth Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
562,324
+50.0%
|
-
|
|
Nov 01
2023
|
Neal J. Sample EVP, Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
193,767
+34.74%
|
-
|
|
Nov 01
2023
|
Holly May EVP, Global Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,091
-1.06%
|
$85,911
$21.08 P/Share
|
|
Nov 01
2023
|
Holly May EVP, Global Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
118,557
+38.06%
|
-
|
|
Nov 01
2023
|
Manmohan Mahajan EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,430
-1.36%
|
$51,030
$21.08 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 2.84M shares |
|---|---|
| Open market or private purchase | 23.5K shares |
| Payment of exercise price or tax liability | 48.7K shares |
|---|---|
| Open market or private sale | 16.2K shares |